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Control over progenitor proliferation and neurogene-
sis remains a key challenge for stem cell neurobi-
ology and a prerequisite for successful stem cell
replacement therapies for neurodegenerative dis-
eases like Parkinson’s disease (PD). Here, we exam-
ined the function of two nuclear receptors, liver X
receptors (Lxra and b) and their ligands, oxysterols,
as regulators of cell division, ventral midbrain (VM)
neurogenesis, and dopaminergic (DA) neuron devel-
opment. Deletion of Lxrs reduced cell cycle progres-
sion and VMneurogenesis, resulting in decreasedDA
neurons at birth. Activation of Lxrs with oxysterol
ligands increased the number of DA neurons in
mouse embryonic stem cells (ESCs) and in wild-
type but not Lxrab/ VM progenitor cultures. Like-
wise, oxysterol treatment of human ESCs (hESCs)
during DA differentiation increased neurogenesis
and the number of mature DA neurons, while reduc-
ing proliferating progenitors. Thus, Lxr ligands may
improve current hESC replacement strategies for
PD by selectively augmenting the generation of DA
neurons.
INTRODUCTION
Understanding how midbrain dopaminergic (DA) neurons are
generated during development and recapitulating such mecha-
nisms in stem cells is a key prerequisite for the development
and improvement of current stem cell replacement strategies
for Parkinson’s disease. In particular, control over the production
of DA neurons versus other cell types, including proliferating
progenitors, remains a key challenge. One approach to achieve
this goal consists of instructing a selective increase in theCnumber and differentiation of DA neurons in stem cell prepara-
tions while reducing the number of non-DA cells, including excess
proliferating progenitors. In this study, we set out to examine
whether liver X receptors (Lxr) and their ligands could affect the
proliferation and number of human embryonic stem cell (hESC)-
derived DA neurons, because Lxrs are known to regulate cell
proliferation in the immune system (Bensinger et al., 2008) and
DA neuron survival in adult mice (Wang et al., 2002).
The liver X receptors (Lxra/NR1H3 and Lxrb/NR1H2) are ligand-
dependent nuclear receptors activated by oxidized derivatives of
cholesterol (oxysterols) (Janowski et al., 1996). Upon binding to
oxysterols, these transcription factors form obligate Lxr-retinoid
X receptor heterodimers that interact with DNA to regulate the
transcription of target genes (Willy et al., 1995; Willy and Mangels-
dorf, 1997; Repa et al., 2002; Zelcer and Tontonoz, 2006) control-
ling cholesterol homeostasis, lipogenesis, and inflammation
(Zelcer and Tontonoz, 2006; Schultz et al., 2000; Venkateswaran
et al., 2000; Alberti et al., 2001; Joseph et al., 2003). Deletion of
Lxra and Lxrb results in impaired cholesterol efflux and lipid
homeostasis, with lipid accumulation in astrocytes and ventric-
ular/periventricular cells during aging (Wang et al., 2002). The
progressive accumulation of lipids in the brain and abnormal
blood-brain barrier of adult Lxr double mutant (Lxrab/) mice
have been reported to contribute to lipid toxicity, increased reac-
tive microglia, astrogliosis, and degeneration of adult spinal cord
motor neuronsand ventral midbrain (VM) DA neurons (Wanget al.,
2002; Andersson et al., 2005; Kim et al., 2008). However, it
remains unknown whether Lxrs regulate the balance between
neurons and glia during early midbrain development and whether
their ligands, oxysterols, regulate such processes.
The generation of the correct proportion of neurons and glia in
neural tissue involves multiple levels of regulation and multiple
players, including proneural genes and cell cycle components.
Although the function of proneural genes has been studied in
the VM, the role of the cell cycle in controlling neurogenesis or
gliogenesis remains unclear. Cell cycle components such as
p27Kip1 have been previously shown to promote primaryell Stem Cell 5, 409–419, October 2, 2009 ª2009 Elsevier Inc. 409
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whereas its inhibition increases Muller glia cells in the retina
(Ohnuma et al., 1999; Levine et al., 2000). In the VM, both neuro-
epithelial and floor plate radial glia-like cells divide to generate
DA neurons (Zervas et al., 2004; Kittappa et al., 2007; Bonilla
et al., 2008). Between embryonic day (E) 10.5 and E13.5, these
cells express the basic helix-loop-helix (bHLH) transcription fac-
tors, neurogenin2 (Ngn2) and mouse achaete-schute homolog 1
(Mash1), but only Ngn2 is required for DA neuron neurogenesis
(Kele et al., 2006; Andersson et al., 2006a). Moreover, the activa-
tion of bHLH proneural genes not only favors neurogenesis, but
represses alternative glia fates in neural progenitors (Tomita
et al., 2000; Nieto et al., 2001; Sun et al., 2001).
Herein, we report that alterations in the cell cycle and in the
expression of Ngn2 in the VM of Lxrab/ mice disrupt the
balance between neurons and glia during development. Our
results show that the number of progenitors undergoing neuro-
genesis in the Lxrab/ mice is reduced, resulting in a predomi-
nantly medial impairment of VM neurogenesis and an accumula-
tion of progenitors and radial glia cells. Interestingly, the
reduction in neurogenesis involves a decrease in the levels of
Ngn2, an ectopic accumulation of phospho-Histone H3+ and
Vimentin+ VM radial glia progenitors in G2/M phase of the cycle,
as well as a decreased cell cycle exit. Conversely, oxysterols
increase neurogenesis and reduce proliferation in murine
midbrain progenitor cultures and hESCs during DA differentia-
tion. Thus, our results identify a novel developmental function
of Lxrs and provide strong evidence that oxysterols can enhance
hESC preparations by specifically increasing VM DA neurons
and reducing unwanted excessive proliferation. These findings
suggest that Lxr ligands may be useful pharmaceuticals to
improve the DA differentiation of hESCs and their application in
drug development and cell replacement therapy for Parkinson’s
disease.
RESULTS
Lxrs Are Expressed in the Ventral Midbrain
during Neurogenesis
Lxra and Lxrb transcripts were detected by quantitative PCR
(qPCR) in the cephalic flexure at E9.5 (Figures 1A and 1B).
Both transcripts were upregulated around E10.5 and E11.5,
the time at which DA neurogenesis begins, suggesting a possible
role for Lxrs in ventral midbrain (VM) DA neurogenesis. At E11.5,
no residual Lxra or Lxrb mRNA was detected by qPCR in the VM
of the corresponding Lxr null mice, confirming the specificity of
the detection (Figure 1G). Lxra and LxrbmRNAs showed a similar
spatial distribution in the forebrain, midbrain, and hindbrain at
E10.5 (Figure 1C) and in the midbrain at E11, as assessed by
in situ hybridization (ISH) in wild-type (WT) mice. We next
focused our attention on the developing VM because adult
Lxrab/ mice exhibit a midbrain phenotype (Wang et al.,
2002). Specifically, Lxra expression was confined to cells close
to the ventricle, whereas Lxrb was expressed throughout the
neuroepithelium of the VM (Figure 1D). The specificity of the
detection of Lxr mRNA was confirmed in the corresponding
null mice (Figure 1F). Consistent with its expression in prolifer-
ating neuroepithelial cells, Lxr expression did not colocalize
with Tuj1-immunoreactive neurons, an early panneuronal marker410 Cell Stem Cell 5, 409–419, October 2, 2009 ª2009 Elsevier Inc.(Figure 1E). Lxrs were also expressed at high levels in E11.5 VM
progenitor-enriched cultures expanded in fibroblast growth
factor 2 (FGF2) for 5 days in vitro (DIV), compared to VM cells
after 1 hr in culture (Figure S1B available online). Interestingly,
high expression levels of enzymes implicated in the synthesis
of oxysterols such as Osc (2,3-oxidosqualene-lanosterol cy-
clase, an enzyme involved in the biosynthesis of cholesterol
Figure 1. Expression of Liver X Receptors in the Developing VM
(A and B) qPCR analysis of Lxra and Lxrb expression in VM during DA neuro-
genesis. VM values were compared to adult liver tissue, attributing a value of 1
to the lowest level of expression (E15.5). Values are mean ± SEM, **p < 0.01
compared to E15.5 by ANOVA with Dunnett’s post-hoc test.
(C) Lxra and Lxrb whole-mount in situ hybridization at E10.5. Lxra expression
was stronger in the midbrain, whereas Lxrb expression was stronger in the
hindbrain (black arrowheads indicate isthmic organizer).
(D–F) Coronal sections through E11–E11.5 VM. Lxra and Lxrbwere detected in
the ventricular zone of WT (ISH), and no colocalization with the postmitotic
panneuronal marker Tuj1 (IHC) was detected in double-stained sections (E).
With the same probe, no Lxrb mRNA was detected in Lxrb/ mice (F).
(G) Lxra and LxrbmRNA levels in the VM of Lxr null mice at E11.5. PCR primers
were specific as Lxra and Lxrb mRNAs were not detected in the respective
knockout embryos.
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terol to 24S-hydroxycholesterol, the most abundant oxysterol
in the brain), and CYP11A1 (that catalyzes the conversion of
several oxysterol intermediates) as well as the expression of
a known Lxr target gene, the cholesterol transporter ABCA1,
were also detected in progenitor-enriched cultures (Figure S1A).
The expression of Osc mRNA and ABCA1 protein in progenitor
cells lining the ventricle were confirmed in mouse E11.5 VM
tissue, by ISH and immunohistochemistry (IHC), respectively
(Figures S1B and S1C). These results show that VM progenitor
cells express oxysterol-synthesizing enzymes, oxysterol recep-
tors, and Lxr target genes, suggesting a possible cell-autono-
mous role of oxysterols and Lxrs in VM development. We thus
set to examine the development of VM progenitors in Lxrab/
mice.
Altered VM Development in the Absence of Lipid
Deposits in Lxrab/ Mice
The development of VM progenitors in the neuroepithelium is
regulated by a precise temporal and spatial expression of
a combinatorial code of transcription and secreted factors that
interact in complex and unique regulatory networks. To gain
insights into the in vivo function of Lxrs in the VM, we examined
Lxr knockout mice at E11.5 for the expression of Sox2, a neural
progenitor cell marker, the ventralizing factor Sonic hedgehog
(Shh; Ye et al., 1998), and the developmental pathway involving
Shh, Foxa2, Lmx1a, and Msx1, implicated in DA specification
(Andersson et al., 2006b; Ferri et al., 2007; Kittappa et al.,
2007). However, none of these genes were significantly altered
(Figure S2). We next analyzed a second genetic network (Fig-
ure 2A) whereby Otx2, Fgf8, and Lmx1b (Ye et al., 2001; Prakash
and Wurst, 2006; Matsunaga et al., 2002; Smidt et al., 2000)
regulate Wnt1, a secreted factor that controls multiple aspects
of DA neuron development (Prakash et al., 2006) and the expres-
sion of a DA neuron-specific gene, Pitx3 (Prakash and Wurst,
Figure 2. Downregulation of Genes Controlling DA
Neuron Development in E11.5 Lxr Null Mice VM
(A) Scheme of theWnt1 genetic cascade. Arrows do not depict
direct regulations or anatomical relations.
(B and C) Q-PCR for Otx2 (B) and Fgf8 (C) in Lxr null mice.
(D) ISH revealed decreased Lmx1b expression and cell reduc-
tion in the floor plate marginal zone (arrows) in Lxrab/ mice.
Discontinuous lines separate progenitors and postmitotic
cells; continuous lines depict floor plate borders.
(E–G) Decreased Lmx1b (E), Wnt1 (F), and Pitx3 expression
levels (G) in Lxr null mice.
(H) Cleaved-caspase-3+ cells in Lxr null mice.
Values are mean ± SEM, n > 3. *p < 0.05; **0.01 < p < 0.001;
and ***p < 0.001 by one-way ANOVA and Fisher’s post hoc
test.
2006; Van den Munckhof et al., 2003). Whereas
the expression of Otx2 and Fgf8 was not regulated
(Figures 2B and 2C), Lmx1b and Wnt1 transcripts
were dramatically decreased in Lxrab/ mice
compared to WT (Figures 2D–2F). Lmx1b tran-
scripts in Lxrab/ embryos revealed a thinner floor
plate with a severe reduction of cells in the marginal
zone, where postmitotic DA cells reside (Figure 2D,
arrows). Moreover, Pitx3, a VM DA-specific transcription factor
required for DA neuron survival and regulated by Lmx1b and
Wnt1 (Prakash et al., 2006; Smidt et al., 2000), was markedly
decreased (Figure 2G). These findings suggested an impairment
of DA neuron development in Lxr null embryos which, unlike the
aging brain (Wang et al., 2002), revealed no accumulation of
lipids by Oil Red O staining (Figure S3). Furthermore, no alter-
ations in the number of pyknotic nuclei (data not shown) or active
caspase-3+ cells were detected (Figure 2H), indicating that no
aberrant apoptosis occurred in these cells. We next examined
whether genes important for DA neuron development, or down-
regulated in the Lxr null mice, were directly controlled by oxyster-
ols, but found that this was not the case (Figure S4). Collectively,
these results excluded a toxic effect of lipids and suggested
an indirect regulation of key midbrain developmental genes.
However, our findings revealed that the embryonic development
of VM DA neurons was affected in the absence of Lxrs. These
findings prompted us to examine whether neurogenesis was
compromised in VM progenitors.
Impaired Neurogenesis in the VM of Lxrab/ Mice
To determine whether VM neurogenesis was affected, we exam-
ined the expression of proneural genes known to regulate this
process (Kele et al., 2006; Andersson et al., 2006a). At E11.5,
Ngn2 was clearly more downregulated in the floor plate than in
the basal plate (Figures 3A and 3B), whereas Mash1 was ex-
pressed at normal levels in the Lxr nulls (data not shown). The
emergence of neurons (Tuj1+/propidium iodide [PI]+ cell bodies)
in the marginal zone of the floor plate was examined at E11.5.
Tuj1+/PI+ neurons were abundant in WT mice, compromised in
Lxra/ and Lxrb/ mice, and severely reduced in the floor plate
of Lxrab/ mice (Figure 3C, arrowheads). These results,
together with the absence of cell death in the Lxr nulls
(Figure 2H), confirmed that neurogenesis was impaired in the
floor plate domain of the midbrain, where DA neurons areCell Stem Cell 5, 409–419, October 2, 2009 ª2009 Elsevier Inc. 411
Cell Stem Cell
Liver X Receptors in Dopamine Neuron DevelopmentFigure 3. Decreased DA Neurogenesis in Lxr Null Mice at E11.5
(A) Reduced Ngn2 in Lxr null mice shown by qPCR (n = 3).
(B–E) VM coronal sections.
(B) ISH revealed a greater loss of Ngn2 in the medial (mfp) and lateral (lfp) floor plate than in the basal plate (bp).
(C) Loss of neurogenesis in Lxr null mice. Tuj1+/PI+ (propidium iodide) neurons (arrowheads) were reduced in the medial floor plate of Lxra/ and Lxrb/ mice.
Neurons and commissural fibers were nearly absent in the medial floor plate of Lxrab/ mice. Dashed lines delineate the border between Tuj1+ and Tuj1 cells in
the medial floor plate. Arrows point to newborn neurons in the intermediate zone of the lateral floor plate.
(D) Impaired Tuj1+ cells in the basal plate (*) of Lxrb/ and Lxrab/ mice.
(E) DA neurogenesis was affected in all Lxr null mice. Arrowheads point to ectopic TH+ processes in the midline neuroepithelium.
(F and G) The number of TH+ and Tuj1+ neurons decreased in all Lxr genotypes (n = 4). Lxra/ mice show selective loss of Tuj1+ cells in the DA compartment.
(H) Nurr1, a marker of postmitotic DA cells, was similarly reduced in the Lxrab/ mice (n = 3).
(I and J) 22-hydroxycholesterol (22-HC, 10 mM) enhanced the percent of TH+ neurons/total Hoechst-33258+ cells in E11.5 VM progenitor cultures from WT but not
Lxrab/ mice (n = 3, in duplicate).
(K–M) 22-HC (10 mM) and overexpression of LXRb-enhanced DA differentiation of mouse embryonic stem cells (mESCs) increasing the number of TH+ neurons.
(K) mESCs were stably transfected with a Flag-LXRb plasmid.
(L) Control and LXRb mESCs were differentiated for 14 DIV ± 22-HC.
(M) Oxysterol treatment and receptor overexpression showed additive effects on TH+ cell number.
(A, F–I, M) Values are mean ± SEM. *p < 0.05; **0.01 < p < 0.001; and ***p < 0.001, by one-way ANOVA and Fisher’s or Dunnett’s (M) post-hoc test.412 Cell Stem Cell 5, 409–419, October 2, 2009 ª2009 Elsevier Inc.
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and tyrosine hydroxylase+ neurons (TH, the rate-limiting enzyme
in the synthesis of DA) revealed an impairment of DA neurogen-
esis in the floor plate (Figures 3D–3G). Although a similar small
number of TH and Tuj1+ cells were lost in Lxra/ mice, a greater
number of Tuj1+ cells than TH+ cells were lost in Lxrb/ and
Lxrab/ mice (Figures 3F and 3G), suggesting a modest but
selective effect of Lxra on DA neurons. Other markers expressed
in midbrain DA precursors and/or neurons, such as Nurr1
(Figure 3H), Lmx1b, and Pitx3 (Figures 2D, 2E, and 2G),
decreased accordingly in all Lxr nulls, with a greater loss in
Lxrab/ mice.
We next examined two other midbrain neuronal populations,
the oculomotor neurons in the floor/basal plate domains and
the g-aminobutyric acid (GABA)ergic neurons in the alar plate
and the dorsal midbrain of Lxrab/ mice (Figure S5). Interest-
ingly, although oculomotor neurons were affected (Islet+ cells),
GABAergic neurons (GABA+ cells) were not. These data show
that the absence of Lxrs affects neurogenesis in a graded fashion
in the VM, with stronger effects on medial neuronal populations
(DA neurons), followed by adjacent lateral cell types (oculomotor
neurons), while having no effect on neurons in the alar plate
(GABAergic neurons). Moreover, Tuj1 expression did not differ
Figure 4. Persistent DA Neuron Loss Is
Accompanied by Increased Radial Glia in
the VM of Lxrab/ Brains at E13.5
(A and B) The loss of DA neurons remained,
whereas an increase in RC2+ progenitors was de-
tected in the Lxrab/ mice (mean ± SEM, n = 6 in
serial sections); *p < 0.05, **0.01 < p < 0.001; and
***p < 0.001 by one-way ANOVA and Fisher’s post
hoc test.
(C and D) Broad increase in RC2+ radial glia cells
and decrease in dorsomedial TH neurons and in
the thickness of the VM (distance from ventricle
to TH+ cells, arrowheads). Dotted line delineates
the ventricle. Note that the intensity of TH staining
was lower in Lxrab/ mice but was enhanced to
allow comparison of cell numbers with WT.
(E–I) At P1, although the loss of DA neurons
persists (TH; E), Lxrab/ mice exhibit no changes
in GFAP+ cell numbers (mean ± SEM) (G). How-
ever, GFAP+ cells show a more fibrous phenotype
and a broader dispersion away from the pial
surface (F, I; arrows), compared to WT (H).
in the dorsal midbrain, cortex, or the
spinal cord at this stage (data not shown),
further indicating that the effects of Lxrs
on neurogenesis are specific to the
medial VM. Because Lxrs are ligand-
dependent nuclear receptors, the effects
of Lxr ligands were tested in E11.5 VM
primary cultures prepared from WT and
Lxrab/ mice. In untreated Lxrab/
cells, few TH+ neurons were detected
(Figure 3I). Administration of 22-(R)-hy-
droxycholesterol (22-HC, Figures 3I and
3J) or the synthetic ligand GW3965
(Figure S6) increased the number of TH+
cells by 2-fold in WT, but not in Lxrab/ primary cultures
(Figures 3I and 3J), indicating that Lxrs mediate the differentia-
tion effects of oxysterols. Notably, the impact of GW3965 on
WT primary VM cultures was of a magnitude similar to those of
GDNF and FGF8, two potent growth factors known to enhance
the differentiation and survival of DA neurons (Figure S6). More-
over, HPLC confirmed the ability of oxysterols to increase the
yield of functional dopamine neurons in primary cultures. DA
release was significantly greater in GW3965-treated than in
vehicle-treated cultures (2.710 ± 0.118 nM and 1.889 ± 0.041
nM, respectively, p < 0.001, Student’s t test). Similar levels of
the DA metabolite, DOPAC, were detected in these cultures
(data not shown), indicating that DA neurons are capable of
utilizing dopamine.
We also examined the capacity of oxysterols and Lxrs to
modulate DA differentiation in mouse embryonic stem cells
(mESCs). In the presence of 22-HC, mESCs differentiated
more efficiently in DA neurons than control cells (2-fold increase
in the number of TH+ cells; Figures 3L and 3M), confirming
the results obtained in primary cultures. LXRb-overexpressing
mESCs (Figure 3K) showed a similar increase in TH+ cell numbers
(Figures 3L and 3M), suggesting that the receptor is also suffi-
cient to enhance DA differentiation in a cell-autonomous manner.Cell Stem Cell 5, 409–419, October 2, 2009 ª2009 Elsevier Inc. 413
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additive effect and cells differentiated in these conditions
showed a 3-fold increase in number of TH+ cells (Figures 3L
and 3M). Thus, our results suggest that oxysterols regulate
Lxr function, which is both required and sufficient for DA
neurogenesis.
A Late Increase in Radial Glia Is Accompanied
by a Partial Rescue of Neurogenesis
We next examined later developmental stages to determine
whether the reduction in DA neurons was maintained and
whether gliogenesis was also altered. At E13.5, during late neu-
rogenesis, a 25%–30% loss of DA neurons was still detected in
Lxrab/ mice (Figures 4A and 4D). TH/Hoechst immunostain-
ings revealed a severe reduction in VM tissue (Figure 4D, dis-
tance between arrowheads), reflecting the persistence of the
neurogenic defect (Figure 4D, arrow). We next assessed the
number of radial glia cells in the floor plate, a cell type recently
identified as a DA progenitor (Bonilla et al., 2008) and capable
of giving rise to glia. Interestingly, the number of RC2+ radial
glia-like cells dramatically increased in the entire VM at E13.5,
showing a 4-fold increase in the Lxrab/ mice (Figures 4B and
4C). At this stage, no GFAP+ astrocytes were detected, indi-
cating that astrogliogenesis did not occur prematurely in
Lxrab/ mice. A partial recovery in TH+ cells was detected at
E13.5 (Figure 4A) compared to E11.5 (Figure 3E). However, the
defect in TH+ neurons was still detected at postnatal day 1
(P1), indicating that part of the neurogenic deficit persisted
Figure 5. Lxrs Control Cell Cycle Progres-
sion and Cell Cycle Exit in VM Progenitors
In Vivo
(A–C) Coronal sections through E12 VM of WT and
Lxrab/ mice pulsed with BrdU (22 hr). (A) Ki67
staining for all active cell cycle phases, (B) BrdU
incorporation, and (C) double-labeled cells.
(D) BrdU cells contributed to increase the total
number of Ki67+ cells in Lxrab/ mice.
(E and F) While the percent of BrdU and Ki67
double-labeled cells increased (E) the percent
BrdU+ cells that exit the cycle and become Ki67
(F) decreased.
(G) Increased Phospho-Vimentin immunoreac-
tive+ radial glial cells in Lxrab/ mice were found
to be mitotic phospho-histone3 (pH3+) cells.
(H and I) Ectopic subapical localization of
increased pH3+ progenitors in late G2/M phase
of the cycle in Lxr null midbrains.
*p < 0.05; **0.01 < p < 0.001 compared to WT by
t test (D–F) or one-way ANOVA and Fisher’s post
hoc test (I). Values are mean ± SEM. n = 3–5
(each, serial sections).
(Figure 4E). This finding, in combination
with the accumulation of radial glia cells
during the neurogenic period (E11.5–
E13.5), suggests that neurogenic radial
glia may play a role in the partial compen-
sation of neurogenesis in Lxrab/ mice.
Analysis of GFAP expression revealed
an increase in GFAP immunoreactivity in
the VM of Lxrab/ mice (Figure 4F), but the number of GFAP
astrocytes was not different compared to WT (Figure 4G). We
thus examined Lxrab/ GFAP+ astrocytes in more detail and
found that, compared to WT mice, they adopted a more fibrous
phenotype and were found further away from the pial surface in
the VM (Figures 4H and 4I). This disorganization of the GFAP+
cells could reflect the alteration in radial glia scaffolds that has
been described in the cerebral cortex of Lxrab/ mice (Fan
et al., 2008). Thus, despite the differences in the distribution
and morphology of astrocytes, our results indicate that astro-
genesis takes place in correct numbers and at the correct devel-
opmental time in the VM of Lxrab/ mice. These data are
consistent with a primary defect in neurogenesis in the devel-
oping VM of Lxrab/ mice and, thus, prompted us to examine
whether the alteration of neurogenesis was due to modified
cell cycle dynamics in VM progenitors.
Decreased Cell Cycle Exit of Lxrab/ Floor Plate
Progenitors during VM Neurogenesis
The regulation of the cell cycle was first examined at E12, after
a 22 hr pulse-chase experiment with bromodeoxyuridine
(BrdU), a synthetic thymidine analog that is incorporated into
the DNA of dividing cells. Whereas the total number of Hoechst+
cells in the floor plate was reduced by 25% in the Lxrab/ mice
compared to WT, the number of progenitors in all active phases
of the cell cycle (Ki67+) increased by 25% in the Lxrab/ mice
(Figures 5A and 5D). This increase in Ki67+ cells was not due
to an increase in the total number of BrdU+ cells (cells in S phase414 Cell Stem Cell 5, 409–419, October 2, 2009 ª2009 Elsevier Inc.
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total number of BrdUKi67+ cells (Figure 5D). Whereas the
percentage of BrdU+ progenitors that remained in the cycle in
the Lxrab/ mice increased (Figure 5E), those exiting the cell
cycle decreased (Figure 5F). Interestingly, we found that cells
accumulating in the neuroepithelium at E11.5 could be specifi-
cally identified as radial glia progenitors in G2/M phase of the
cell cycle (Figure 5G), as they were stained with an antibody
against the radial glia marker phospho-Vimentin (p-Vim; phos-
phorylated by cdc2 kinase at Ser55) and the mitotic marker
phospho-Histone H3+ (pH3+). In agreement with this, a 20%
increase in RC2+ fibers was detected in Lxrab/ mice at
E11.5 (data not shown). In WT mice, the cell bodies of p-Vim+
and mitotic pH3+ progenitors were positioned close to the
ventricular cavity (Figure 5H). In contrast, p-Vim+ cells and
p-H3+ progenitors increased in number and were detected in
ectopic subapical positions in Lxrab/ mice (Figures 5G–5I).
Quantification of the number of pH3+ cells showed significant
increases in Lxra/ and Lxrb/ mice (22% and 31%, respec-
tively), reaching up to 45% in Lxrab/ embryos (Figures 5H
and 5I). These results indicate that cell cycle progression is de-
layed and/or impaired at G2/M, leading to an accumulation of
progenitor cells and an impairment of neurogenesis. Ngn2
expression decreases in the VM of Lxrab/ mice, and Ngn2
has been previously shown to promote neurogenesis via interac-
tion with the cyclin-dependent kinase inhibitor p27Kip1 (Nguyen
et al., 2006), so the expression of p27Kip1 was examined. Inter-
estingly, p27Kip1 mRNA was decreased in the VM of Lxrab/
mice at E11.5 (Figure S7A). This result was also supported by
gain-of-function experiments in VM neurosphere cultures
treated with oxysterols. In this system, we found an increase in
p27Kip1 and TH protein levels, as well as an increase in the phos-
pho-histone gH2A.X (gH2A.X; S139), a checkpoint protein phos-
phorylated in healthy cells during DNA synthesis and G2/M
(Huang et al., 2005), but not in phospho-retinoblastoma (pRb;
S805/811), a regulator of cell cycle progression from G1 to
S phase (Figure S7B). Thus, our results indicate that oxysterols
affect cell cycle regulators known to promote cell cycle pro-
gression and favor differentiation of VM progenitors during
neurogenesis.
Oxysterols Promote Neurogenesis and Reduce
Proliferation of Progenitors in hESC Preparations
during DA Differentiation
Next we examined whether oxysterols could promote DA neu-
rogenesis and reduce proliferation and gliogenesis in two differ-
entiating hESC lines, H9 and HS181 (Figure 6A). LXRa and LXRb
transcripts were detected in hESCs and their expression
increased during differentiation (data not shown). Administration
of oxysterols during differentiation increased the percentage of
Tuj1+ neurons by 70% and of TH+ neurons by 300% (Figure 6B).
Maximal neurogenic effects were obtained at 0.1–0.5 mM of
22-HC (Figure 6B), and signs of toxicity and cell loss were
detected only at doses R5 mM (data not shown). Interestingly,
the proportion of TH+ cells out of the total Tuj1+ population
increased from 22% to 60%. The expression of phenotypic
markers of midbrain DA neurons was examined in TH+ cells
derived from 22-HC-treated H9 (passage 35) and HS181 (passage
40; data not shown) cultures. TH+ cells in oxysterol-treatedFigure 6. 22-HC Improves DA Specification and Neurogenesis while
Decreasing the Number of Proliferative Progenitors and Astrocytes
in hESC Preparations
(A) Protocol for the DA differentiation of hESCs.
(B) 22-HC increased the number of neurons in a dose-dependent manner, and
predominantly the number of TH+ cells.
(C) TH+ cells expressed typical markers of midbrain DA neurons (LMX1a, EN1,
NURR1, PITX3, DAT) and substantia nigra DA neurons (GIRK2). GABA+ and
5HT+ cells within the cultures were very rare, illustrating the specificity of the
oxysterol effects on VM DA neurons.
(D) 22-HC reduced the number of GFAP+ astrocytes, NESTIN+ neural progen-
itor/stem cells, and Ki67+ proliferative progenitors. Similar changes were
obtained with H9 and HS181 cell lines (data not shown).
Values are mean ± SEM, n > 3, *p < 0.05 and **0.01 < p < 0.001 by one-way
ANOVA and Dunnett’s post hoc test.Cell Stem Cell 5, 409–419, October 2, 2009 ª2009 Elsevier Inc. 415
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LMX1a, ENGRAILED1, NURR1, PITX3, the potassium channel
typical of VM nigral neurons, GIRK2, and DAT (Figure 6C),
but only few were CALBINDIN+ (data not shown). Moreover,
very few GABA+, Serotonin+ (5HT), and DBH+ neurons were
detected in the hESC cultures (Figure 6C and data not shown).
These results were indicative of a selective enhancement of
DA neuron development by oxysterols in our culture condi-
tions. Moreover, a dramatic decrease in the number of
GFAP+ astrocytes, neural stem/progenitor cells (NESTIN+),
and Ki67+ proliferative progenitors was also detected
(Figure 6D). Thus, our findings indicate that neuralized hESC
lines treated with SHH and FGF8 respond to oxysterols, by
giving rise to higher numbers of VM DA neurons and reducing
the number of astrocytes and proliferating progenitors. Similar
results were obtained in VM cultures, where administration of
oxysterols reduced the number of proliferating progenitors
(Figure S8). Together our data confirm that LXR ligands can
be used to reduce progenitor proliferation and enhance the
generation of midbrain DA neurons from hESCs or primary
VM progenitors.
DISCUSSION
The generation of correct numbers of neurons and glia in the
developing CNS is a highly regulated process, coordinated by
the expression of several factors including transcription factors,
cell cycle components, morphogens, and growth factors (Shen
et al., 2006; Miller and Gauthier, 2007; Dehay and Kennedy,
2007; Nguyen et al., 2006). In this report, we provide the first
genetic evidence that the liver X receptors a and b (Lxra and b)
regulate three essential aspects of this process in VM progeni-
tors: the expression of midbrain developmental genes, the regu-
lation of VM neurogenesis, and cell cycle progression and exit.
Genetic ablation of Lxrs leads to impaired VM development
that mainly affected the medial VM and DA neurons. Conversely,
Lxr agonists, oxysterols, increased DA neurogenesis in VM
cultures. Moreover, deletion or overexpression of Lxrs also
ablated or enhanced the effects of oxysterols on DA neurogene-
sis, indicating that Lxrs are both required and sufficient to
mediate the effects of oxysterols and that the effects of Lxrs
are, at least in part, cell autonomous. The regulation of neuro-
genesis that we observed was highly specific to VM cells, as
manifested by the regulation of the number of Tuj1+ cells in the
midbrain floor plate, but not in the cerebral cortex, the dorsal
midbrain, or the spinal cord of Lxrab/ mice at E11.5. Gene
regulation was also very specific, as shown by the fact that
only a subset of typical midbrain developmental genes such as
Lmx1b, Wnt1, Ngn2, and Pitx3, but not Shh, Foxa2, Lmx1a, or
Otx2,were downregulated in Lxrab/mice. Similarly, oxysterols
were found to specifically increase DA neurogenesis during DA
differentiation of VM and hESC cultures.
In the developing VM, floor plate progenitor cells located
around the ventricle were found to be both the primary source
and targets of oxysterols, as they express oxysterol-synthesizing
enzymes, Lxra and b receptors, and Lxr target genes, such as
the ABCA1 transporter protein for cholesterol and its derivatives
(Figure 1 and Figure S1). These results suggest that progenitor
cells in the VM floor plate respond to cholesterol derivatives,416 Cell Stem Cell 5, 409–419, October 2, 2009 ª2009 Elsevier Inc.like oxysterols, in an autocrine or paracrine manner. In particular,
the fact that the 24,25-epoxycholesterol-synthesizing enzyme,
Osc, was highly expressed in VM progenitor cells, suggests
that this cholesterol derivative might be one of the sources of
Lxr activation in this region during development.
Based on these results, we analyzed the development of the
VM in the absence of Lxrs, the oxysterol-responsive receptors.
We first found a loss of VM neurons, which was not accompanied
by lipid deposits or metabolic defects (Figures S3 and S9) but
rather by a decrease in the expression of midbrain develop-
mental genes. These included Ngn2 and Wnt1, which regulate
neurogenesis (Kele et al., 2006; Castelo-Branco et al., 2003),
as well as Lmx1b, Wnt1, and Pitx3, which regulate cell survival
(Smidt et al., 2000; Van den Munckhof et al., 2003; Prakash
et al., 2006), among other functions. Although a direct in vivo
regulation by Lxrs is possible, our in vitro results indicate that
oxysterols do not directly regulate the expression of develop-
mental genes in progenitor cells (Figure S4). When the possible
effects of these developmental genes on survival or neurogene-
sis were examined, we found no signs of increased cell death,
but a clear defect in VM neurogenesis (Figure 3). Two different
mechanisms could explain this result: a neuron versus glia fate
change, or a cell cycle deregulation during neurogenesis. A
switch in the primary fate decision between neuron and glia
(Tomita et al., 2000; Nieto et al., 2001; Sun et al., 2001) would
involve a complete loss of proneural bHLH gene expression
and a premature appearance of glia. However, we found that
whereas Ngn2 expression is markedly downregulated, Mash1
expression is normal in the Lxr null mice. Moreover, neurogene-
sis is partially rescued by DA neurons born at a later stage and
gliogenesis is not accelerated or enhanced, ruling out the possi-
bility of a fate switch. Interestingly, although the loss of DA
neurons in the medial floor plate could in part be attributable to
the decrease in Ngn2 (Kele et al., 2006), the accumulation of
radial glia-like cells and the loss of oculomotor neurons indicate
the involvement of an additional process regulated by Lxrs.
Indeed, our results show a severe alteration in cell cycle
dynamics during early neurogenesis. Although the number of
cells that proceeded through S phase (BrdU+) in WT and
Lxrab/ progenitors was not different, the number of progeni-
tors in the cell cycle (Ki67+) increased by 25% in Lxrab/
mice. In addition, we also detected a decrease in cell cycle
exit in Lxrab/ mice compared to WT, but no increase in cell
death (pyknotic nuclei or active Caspase-3+ cells). These results
indicate that Lxrab/ VM progenitors accumulate in the cycle.
Accordingly, the proportion of Ki67+ VM progenitors that were
not labeled by BrdU increased by 2-fold in Lxrab/ mice, and
phospho-Histone-3+ progenitors and phospho-Vimentin+ radial
glia cell bodies accumulated ectopically in a subapical position in
late G2/M phases. This accumulation was greater in Lxrab/
than in Lxrb/ or Lxra/ mice, an observation that correlates
with the loss of neurogenesis. In sum, our findings are consistent
with an impairment of cell cycle progression that leads to a
reduction in cell cycle exit in Lxrab/ VM progenitors and
a progressive accumulation of radial glia progenitors in G2/M
during the neurogenic period, from E11.5 to E13.5 (Figures 4B,
4C, and 5G). This alteration is consistent with the reduced
number of neurons and the increased number of radial glia cells
in the embryonic VM.
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macrophages (Bensinger et al., 2008) in a similar manner as
we hereby describe for Lxrab/ mice in VM neurons. Although
the precise mechanisms by which Lxrs regulate the cell
cycle are not known, the regulation of cell cycle components
such as p27Kip1 has been described to differentially control cycle
exit during neurogenesis. Indeed, inhibition or loss of p27Kip1
decreases early-born neurons (Goto et al., 2004), whereas over-
expression of p27Kip1 accelerates differentiation (Nguyen et al.,
2006). In agreement with this, we found that oxysterols increased
levels of p27Kip1 and TH, and deletion of Lxrs reduced p27Kip1
and the number TH+ DA neurons. Thus, our data showing
reduced levels of p27Kip1 and Ngn2 in the VM of Lxrab/ mice
agrees with the finding that the embryonic VM phenotype of
Lxrab/ null mice is contributed by a defect in neurogenesis
and by a decrease in cell cycle progression and cell cycle exit
during neurogenesis.
In our study, we also verified the function of oxysterols/LXR in
human cells and examined the usefulness of LXR ligands in stem
cell platforms that could be used for drug discovery, regenera-
tive medicine, or cell replacement therapies for PD (Parish and
Arenas, 2007). Protocols for the efficient differentiation of hESCs
into DA neurons have been developed during recent years (Per-
rier et al., 2004; Cho et al., 2008; Yang et al., 2008; Roy et al.,
2006). However, several factors currently prevent the clinical
use of hESCs: (1) the limited survival of hESC-derived DA
neurons after grafting (1%–2.7% of the total in the best cases);
(2) the incomplete specification or differentiation of stem cells
(presence of forebrain or progenitor/retention of stem cell
markers); and (3) the excessive proliferation of neural progeni-
tors. Our results suggest that oxysterols may limit the impact
of some of these factors and enhance the therapeutic potential
of hESCs by promoting DA neurogenesis and the acquisition of
a midbrain dopaminergic phenotype as well as by reducing the
proliferation of progenitors.
In conclusion, our findings suggest that the previously re-
ported lipid deposition, gliosis, and degeneration of neurons as
a result of a toxic insult in aged Lxr knockout animals (Wang
et al., 2002) are very late events after a profound developmental
alteration that takes place during embryonic development. The
initial loss of DA neurons in Lxrab/ mice results from an alter-
ation in cell cycle progression/exit in the VM and an impairment
in DA neurogenesis. Interestingly, we found that the functions of
LXRs are conserved in human cells and that oxysterols can be
used to improve the number and properties of hESC-derived
DA neurons. Thus, our report provides the first genetic evidence
of a function of Lxra and Lxrb in early midbrain DA development.
Moreover, we demonstrate that oxysterols increase DA neurons
and reduce proliferation in hESC preparations. These data
suggest that LXR ligands may facilitate the application of hESCs
to drug discovery and cell replacement for PD.
EXPERIMENTAL PROCEDURES
Lxr Null Mice and Immunohistochemistry
Experiments were performed with C57BL/6, Lxra/, Lxrb/, and Lxrab/
mice with approval of the local ethical committees (Stockholms Djurfo¨rso¨ke-
tiska Na¨mnd). Time-mated embryos were fixed, cryopreserved, and frozen
at 80C. Immunohistochemistry (IHC) was performed on 4% paraformalde-
hyde (PFA)-fixed serial coronal 14 mM sections and with the antibodies listed inCSupplemental Data. For BrdU analysis, pregnant mice were injected with
50 mg BrdU/kg body weight at 5 mg/ml in PBS 22 hr before sacrifice. Histolog-
ical sections were treated with 2N HCl for 15 min prior to detection with a BrdU
antibody. Stainings were visualized with a Zeiss HBO100 microscope and
images were collected with a Hamamatsu camera C4742-95 and processed
with OpenLab software. For quantifications, sections throughout the VM (every
35 mm) were stained and quantified at different stages (n = 3–4 animals per
genotype). Tuj1+, TH+ cells were identified as immunoreactive somas sur-
rounding an empty or a propidium iodide-stained nucleus. RC2+ processes
in contact with the pial surface and within the VM area containing TH+ cells
were counted. For P1 tissue, all VM GFAP+ cells (with Hoescht nuclear coun-
terstain as reference) were counted in three animals per genotype. For the
staining of neutral lipids, VM sections were stained with an Oil Red O (Sigma)
solution (1 mg/ml) for 5–10 min. Next, the slides were rinsed with 60% isopro-
panol for 5 min to remove background and dissolve unincorporated stain and
analyzed immediately.
Q-PCR
RNA was isolated from (1) WT mouse ventral midbrain or ventral cephalic
flexure dissected from three to five embryos (from E9.5 to E15.5), (2) Lxr nulls
and controls (n = 3–5 per genotype) VM dissected at E11.5, (3) three indepen-
dent preparations of progenitor-enriched mouse VM E11.5 cultures (Bonilla
et al., 2008), or (4) three independent preparations of neurospheres derived
each from a pool of at least nine VMs dissected at E11.5. Total RNA was ex-
tracted and reverse transcribed, and real-time qPCR assays were performed
as previously described (Rawal et al., 2006). Standard curves were generated
with serial dilutions of a reverse-transcribed RNA from VM or adult liver and the
derived Ct values were converted into arbitrary quantities and then normalized
with values of house-keeping genes obtained in parallel assays. More details
are described in Supplemental Data.
In Situ Hybridization
In situ hybridization (ISH) on sections of WT and Lxrab/ E11–11.5 mouse
embryos was performed as previously described (Kele et al., 2006), with DIG-
labeled single-stranded RNA probes for Ngn2, Lmx1b, Lxra, Lxrb, and 2,3-
oxidosqualene-lanosterol cyclase (Osc). Specific primers were used to
generate amplicons of 1180 base pairs for the Lxra sequence (NT_039207),
1269 bp for the Lxrb sequence (NM_009473), 500 bp for the Osc sequence
(NM_146006), 499 bp for the CYP46A1 sequence (NM_010010), and 450 bp
for the CYP11A1 sequence (NM_019779) from adult liver cDNA and trans-
formed into the pCRII-TOPOvector (Invitrogen) according to themanufacturer’s
protocol. Whole-mount ISH was performed on E10.5 embryos essentially as
described (Wilkinson and Nieto, 1993) with the above-described Lxr probes.
Primary VM Cultures
VMs were manually dissected, plated on poly-D-lysine (150,000 cells/cm2),
and grown in serum-free N2 media consisting of 1:1 mixture of F12 and
DMEM with 10 ng/mL insulin, 100 mg/mL apo-transferrin, 100 mM putrescine,
20 nM progesterone, 30 nM selenium, 6 mg/ml glucose, and 1 mg/ml BSA.
Cells were treated for 3 days in vitro (DIV), as specified in figure legends,
and fixed with 4% PFA. For BrdU analysis, pulsed cells were treated for
30 min with 2N HCl and then processed as described in Supplemental Data.
Hoechst staining was performed by permeabilizing cells with a 0.3% Triton
X-100/PBS solution for 5 min followed by incubation with Hoechst 33258
(Sigma) for 10 min. Cells were counted and images were collected on a Zeiss
Axioplan 100M microscope (LD Achrostigmat 203, 0.3 PH1 0-2 and LD Ach-
roplan 403, 0.60 Korr PH2 0-2).
Mouse Embryonic Stem Cell Cultures and Human ESCs
mESCs (R1) were cultured as described in Supplemental Data. Proliferating
cells were nucleofected with expression vectors (pCMV-hLXRBeta/FLAG-
Ires-Neo or pCMV-Empty/FLAG-Ires-Neo, as a control), according to protocol
supplied by the manufacturer (mouse ESC nucleoporator kit, AMAXA), and
seeded on gelatin coated-plates in mESC medium. Neomycin (Geneticin,
G-418, Invitrogen) selection (300 mg/ml) started 48 hr postnucleofection and
was maintained for 1 month. Neural differentiation was induced by coculture
on PA6 stromal cells, in accordance with the 14DIV protocol by Barberi et al.
(2003). mESCs were plated at low density (150 cells/cm2) on a confluent layerell Stem Cell 5, 409–419, October 2, 2009 ª2009 Elsevier Inc. 417
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ml) were added to the medium. After 8 days, cultures were switched to N2
medium in the presence of SHH, FGF8, and FGF2 (10 ng/ml). At day 11 SHH
and FGF8 were withdrawn, following the differentiation until day 14 in medium
N2 containing ascorbic acid (AA; 0.2 mM), brain-derived neurotrophic factor
(BDNF; 20 ng/ml), and glial cell line-derived neurotrophic factor (GDNF;
10 ng/ml). Treatments with or without 22-HC (0.5 mM) started on day 8 until
the end of differentiation.
Cell Counts and Statistical Analyses
Percentages of Tuj1+ or TH+ colonies related to total colonies. The size of the
colonies vary greatly within the same condition but do not differ from one
condition to another, so the number of TH+ cells was counted and referred
to the area occupied by these colonies, to correct for size variation. The
same number of colonies were counted in each condition, and the area unit
used was 6250 mm2. Data from different groups were compared with
ANOVA and Dunnett´s Multiple Comparison post hoc analysis (GraphPad
Prism). All data are expressed as mean ± SEM.
For hESC cultures, the hESC lines H9 (Thomson et al., 1998) (46XX,
passages 35–55, WiCell license SLA#02-W183) and HS181 (46XX, passages
35–60) were cultured as previously described (Imreh et al., 2006). Neural differ-
entiation of hESCs was induced by means of coculture on PA6 stromal cells
(Perrier et al., 2004). hESCs were plated at 20 3 103 cells on a confluent layer
of PA6 cells in 6 cm cell culture plates. At day 12, SHH (200 ng/ml) and FGF8
(25–100 ng/ml) were added to the medium. After 16 days, cultures were
switched to N2 medium in the presence of SHH, FGF8, BDNF (20 ng/ml),
and AA (0.2 mM; Sigma). At day 20, SHH and FGF8 were withdrawn, after
the differentiation until day 25–28. Rosette structures containing neural precur-
sors were manually isolated and replated on PO/L-[polyornithine (15 mg/ml)/
Laminin (1 mg/ml)]-coated culture dishes in N2 medium supplemented with
SHH, FGF8, FGF2 (10 ng/ml), AA, and BDNF (Passage 1, indicated ‘‘P1’’ in
Figure 6A). After 1 week, cells were mechanically passaged after exposure
to Ca2/Mg2-free Hanks balanced salt solution (HBSS; Invitrogen) for 1 hr at
room temperature and spun at 200 3 g for 5 min (Passage 2, indicated ‘‘P2’’
in Figure 6A). Cells were resuspended in N2 medium and replated onto PO/
L-coated dishes (50–100 3 103 cells per cm2) in the presence of SHH,
FGF8, AA, BDNF, and different concentrations of 22-HC. After 7 days, cells
were differentiated in the absence of SHH and FGF8 but in the presence of
BDNF, GDNF (10 ng/ml), transforming growth factor type B3 (1 ng/ml), dibutyril
cAMP (0.5 mM), AA, and different concentrations of oxysterols for one more
week. For IHC, cells were fixed in 4% PFA and stained with antibodies listed
in Supplemental Data.
Cell Counts and Statistical Analyses
Percentages of TH- or Tuj1-positive neurons were obtained from four different
experiments for both human cell lines (H9 and HS181); 10 to 15 random fields
per well were analyzed. Percentages were compared with one-way ANOVA
and Dunnett’s Multiple Comparison post-hoc analysis (GraphPad Prism). All
data are expressed as mean ± SEM.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and nine
figures and can be found with this article online at http://www.cell.com/
cell-stem-cell/supplemental/S1934-5909(09)00403-2.
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